Package 66993-134-97

{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "bffa73f4-99ab-49a2-b585-0982dd611110", "openfda": {"unii": ["7AN603V4JV", "40AHO2C6DG"], "rxcui": ["1487527"], "spl_set_id": ["6de414b1-f707-4b98-9e4b-742032ec90af"], "manufacturer_name": ["Prasco Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TRAY in 1 CARTON (66993-134-97)  / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER", "package_ndc": "66993-134-97", "marketing_start_date": "20250411"}], "brand_name": "Umeclidinium and Vilanterol Ellipta", "product_id": "66993-134_bffa73f4-99ab-49a2-b585-0982dd611110", "dosage_form": "POWDER", "pharm_class": ["Adrenergic beta2-Agonists [MoA]", "Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "beta2-Adrenergic Agonist [EPC]"], "product_ndc": "66993-134", "generic_name": "umeclidinium bromide and vilanterol trifenatate", "labeler_name": "Prasco Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Umeclidinium and Vilanterol Ellipta", "active_ingredients": [{"name": "UMECLIDINIUM BROMIDE", "strength": "62.5 ug/1"}, {"name": "VILANTEROL TRIFENATATE", "strength": "25 ug/1"}], "application_number": "NDA203975", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20250411", "listing_expiration_date": "20261231"}